NRNP 6665 Week 4: Mood Disorders in Adults Essay
NRNP 6665 Week 4: Mood Disorders in Adults Essay
I am finally doing everything right. I stayed up all night studying for my final exams and even managed to clean out my closet and order a whole new bedroom from the internet. I know I will ace all my exams. Nothing can go wrong like they did a few months ago. I was so low and was sleeping all the time. I did not think I would ever be happy again, but now I know I can do anything.
—Jessica, age 22
Patients presenting with mood disorders may find that their moods impact their ability to function or that their moods are not consistent with their circumstances. Bipolar and related disorders are one category of mood disorders. They affect nearly 3% of the U.S. population each year (Depression and Bipolar Support Alliance, n.d.). Although being relatively rare in terms of lifetime prevalence, bipolar disorder is burdensome to the individual and health care system because of its early onset, severity, and chronic nature. The average age of onset is around 25 and it affects men and women equally.
The importance of evidence-based intervention for treatment in persons with mood disorders cannot be underestimated. Unstable moods can result in repeat chronic hospitalizations and profound life disruption. Mood disorders are a leading cause of disability worldwide and can contribute to suicide (World Health Organization, 2020). Practitioners should understand that developing a good
rapport and relationship with the patient can make a significant difference in the course, symptom management, and stability of the patient.
Click here to ORDER an A++ paper from our MASTERS and DOCTORATE WRITERS: NRNP 6665 Week 4: Mood Disorders in Adults Essay
This week, you will assess, diagnose, and develop appropriate treatment plans for adults presenting with mood disorders.
Reference:
Depression and Bipolar Support Alliance. (n.d.). Bipolar disorder statistics. https://www.dbsalliance.org/education/bipolar-disorder/bipolar-disorder-statistics/#
World Health Organization. (2020). Depression. https://www.who.int/news-room/fact-sheets/detail/depression
Learning Objectives
Students will:
- Assess adults presenting with mood disorders
- Develop differential diagnoses for adult patients with mood disorders
- Develop appropriate treatment plans for adult patients with mood disorders
- Advocate health promotion and patient education strategies for adult patients with mood disorders
Learning Resources
Required Readings (click to expand/reduce)
Sadock, B. J., Sadock, V. A., & Ruiz, P. (2015). Kaplan & Sadock’s synopsis of psychiatry (11th ed.). Wolters Kluwer.
- Chapter 8, “Mood Disorders”
Zakhari, R. (2020). The psychiatric-mental health nurse practitioner certification review manual. Springer.
- Chapter 11, “Mood Disorders”
Document: Focused SOAP Note Template
Document: Focused SOAP Note Exemplar
Required Media (click to expand/reduce)
Walden University. (2021). Case study: Petunia Park. Walden University Blackboard. https://class.waldenu.edu
Accessible player –Downloads– Download Video w/CC Download Audio Download Transcript
Medication Review
Review the FDA approved use of the following medicines related to treating mood disorders.
Click here to ORDER an A++ paper from our MASTERS and DOCTORATE WRITERS: NRNP 6665 Week 4: Mood Disorders in Adults Essay
Depression | Premenstrual dysphoric disorder | Seasonal affective disorder (MDD with Seasonal Variation) | |||
agomelatine amitriptyline amoxapine aripiprazole (adjunct) brexpiprazole (adjunct)bupropion citalopram clomipramine cyamemazine desipramine desvenlafaxine dothiepindoxepin duloxetine escitalopram fluoxetine fluvoxamine iloperidone imipramine isocarboxazid ketamine lithium (adjunct) l-methylfolate (adjunct) |
lofepramine maprotiline mianserin milnacipran mirtazapine moclobemide nefazodone nortriptyline paroxetine phenelzine protriptyline quetiapine (adjunct) reboxetine selegiline sertindole sertraline sulpiride tianeptine tranylcypromine trazodone trimipramine venlafaxine vilazodone vortioxetine |
citalopram desvenlafaxine duloxetin eescitalopram fluoxetin eparoxetine pepexev sarafe, sertraline venlafaxine |
Bupropion HCL extended-release | ||
Bipolar depression | Bipolar disorder (mixed Mania/Depression | Bipolar maintenance | Mania | ||
lithium (used with lurasidone) lurasidone olanzapine-fluoxetine combination (symbyax) quetiapine valproate (divalproex) (used with lurasidone) |
aripiprazole asenapine carbamazepine |
olanzapine ziprasidone |
aripiprazole
lamotrigine |
aripiprazole asenapine carbamazepine lithium olanzapine quetiapine risperidonevalproate (divalproex) ziprasidone |